Cardiovascular Disease

SEATTLE — Higher post-dexamethasone cortisol was associated with lower estimated glomerular filtration rate independent of cardiovascular risk factors, researchers reported at the AACE Annual Scientific and Clinical Conference.

Results of a Mendelian randomization study support a causal role of several reproductive factors on women’s risks for cardiovascular disease, according to researchers.

SAN DIEGO — There are several new cardiology updates on treatment and concepts regarding heart failure, hypertension and aging, according to a speaker at the ACP Internal Medicine Meeting.

Infections that require hospital treatment were associated with increased risk for major cardiovascular disease events immediately after hospitalization, with a small increased risk in the long term, researchers reported.

An increasing number of studies are reporting that testosterone therapy may not only normalize testosterone levels for men, but may also provide cardiometabolic benefits.

Providers are too cautious with testosterone therapy. The myth is that increasing testosterone level will cause prostate cancer. If you start with a myth, you have to disprove that myth with a trial that is probably too big to ever conduct and that nobody will ever fund. Although repeated studies have shown no risks with testosterone therapy, those small studies are never looked at.

It is estimated that one in two U.S. adults has hypertension, considered the most prevalent CV condition and a potent risk factor for MI, HF, stroke and death. Yet, BP control continues to worsen, and the disease burden remains substantial.